Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

60.68USD
22 Jun 2017
Change (% chg)

$0.63 (+1.05%)
Prev Close
$60.05
Open
$60.00
Day's High
$60.98
Day's Low
$59.91
Volume
765,372
Avg. Vol
851,512
52-wk High
$60.98
52-wk Low
$42.22

Select another date:

Wed, Jun 14 2017

BRIEF-Baxter announces agreement with Dorizoe Lifesciences to further expand generic injectables pipeline

* Baxter announces agreement with dorizoe lifesciences to further expand generic injectables pipeline

BRIEF-Baxter announces U.S. FDA approval, commercial launch of ready-to-use clindamycin injection in saline

* Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline

BRIEF-Third Point Llc reports a stake of 7.5 pct in Baxter International

* Third Point Llc reports a stake of 7.5 percent in Baxter International as of June 1

BRIEF-Baxter and Mayo Clinic launch R&D collaboration to transform patient care

* Baxter and Mayo Clinic launch research and development collaboration to transform patient care

BRIEF-Third Point LLC dissolves share stake in Apple, Goldman Sachs

* Third Point LLC dissolves share stake in Apple Inc - sec filing

BRIEF-Baxter International says in April became aware of criminal investigation by antitrust division of DOJ- SEC filing

* in April 2017, co became aware of criminal investigation by U.S. DOJ, antitrust division and federal jury in U.S. District court for eastern district of Pennsylvania-filing

BRIEF-Baxter International says received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

* Baxter International Inc - received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

BRIEF-Baxter raises quarterly dividend

* Baxter International Inc - sets qtrly dividend of 13 cents per share Source text for Eikon: Further company coverage:

BRIEF-Baxter International Q1 revenue $2.5 billion

* Baxter reports first-quarter 2017 results and increases financial outlook for full-year 2017

BRIEF-Walgreens Boots Alliance elects Baxter International CEO José Almeida to its board

* José E. Almeida, chairman and ceo of Baxter International, elected to Walgreens Boots Alliance board of directors

Select another date:

More From Around the Web